Robert Stianchi

Bio:

Rob Stianchi is Associate Vice President of U.S. Oncology, leading the Women’s Cancers portfolio, strategic alliances with Eisai and AstraZeneca, and commercial planning for upcoming pipeline products. He brings more than 20 years of broad biopharmaceutical experience across U.S. and global commercial strategy, oncology & specialty marketing, precision medicine, analytics and forecasting, corporate strategy, and operational excellence.

Throughout his career, Rob has led major oncology portfolios and launch strategies, including work across bladder cancer, precision medicine, biosimilars, and other solid tumors. He is recognized for combining a strong strategic mindset with disciplined execution, clear communication, and an ability to align diverse cross-functional teams around shared priorities. His leadership approach emphasizes collaboration, thoughtful decision-making, talent and capability development, and translating complex scientific and commercial opportunities into strategies that support patients and business growth.

Outside of work, Rob is a dedicated distance runner who has completed more than 30 marathons. His other interests include Scouting and smart-home improvement projects.